Endocrine vasculatures are preferable targets of an antitumor ineffective low dose of anti-VEGF therapy
about
VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis.Discontinuation of anti-VEGF cancer therapy promotes metastasis through a liver revascularization mechanism.Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia.Ablation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning.Dual roles of endothelial FGF-2-FGFR1-PDGF-BB and perivascular FGF-2-FGFR2-PDGFRβ signaling pathways in tumor vascular remodeling.Maintenance of antiangiogenic and antitumor effects by orally active low-dose capecitabine for long-term cancer therapy.[Application of Bevacizumab in Non-small Cell Lung Cancer].
P2860
Q33748993-F1E050BE-864A-49E3-8805-72841122BC3AQ37260920-BC8353B5-050D-4A6C-9F42-9FB9C626CAD7Q37588345-4568E262-620F-4DED-BC6F-B5BDB08E3382Q47203673-77B914D5-39BB-4429-BC3E-BEED1E886D8BQ49384248-D7E7A3FE-EEFB-4EC7-99A8-98BCAD450D06Q52682124-5A767AE4-F366-442C-878E-BD7BFB3E34AEQ55556494-F26E6320-BCF8-4787-B305-9B0FF4A14A5C
P2860
Endocrine vasculatures are preferable targets of an antitumor ineffective low dose of anti-VEGF therapy
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Endocrine vasculatures are pre ...... low dose of anti-VEGF therapy
@en
type
label
Endocrine vasculatures are pre ...... low dose of anti-VEGF therapy
@en
prefLabel
Endocrine vasculatures are pre ...... low dose of anti-VEGF therapy
@en
P2093
P2860
P356
P1476
Endocrine vasculatures are pre ...... low dose of anti-VEGF therapy
@en
P2093
Guichun Huang
Jingwu Zang
Kayoko Hosaka
Yunlong Yang
P2860
P304
P356
10.1073/PNAS.1601649113
P407
P577
2016-03-28T00:00:00Z